Skip to main content
WorldVoice 360
PoliticsNew Jersey

3M to Settle for $450 Million Over Toxic Water Contamination in New Jersey

The agreement addresses the pollution of drinking water caused by harmful 'forever chemicals,' commonly known as PFAS, in the state.

By Hiroko TabuchiSource: nytimes.com1 min read
3M to Settle for $450 Million Over Toxic Water Contamination in New Jersey
Image via nytimes.com

In brief

The landmark deal represents a significant step in the ongoing battle against industrial pollution in New Jersey.

3M, the prominent Minnesota-based chemicals manufacturer, has agreed to pay New Jersey up to $450 million to resolve allegations of drinking-water contamination linked to harmful substances known as “forever chemicals” or PFAS. These chemicals were produced at the Chambers Works facility in Deepwater, a site that has a history of industrial activity on the banks of the Delaware River.The settlement, recognized as the largest clean-water agreement in New Jersey's history, was prompted by a lawsuit filed by the state in 2019 against 3M, DuPont, and other manufacturers. New Jersey officials claimed that operations at the Chambers Works site resulted in significant contamination of local groundwater, posing serious risks to drinking water.PFAS, short for per- and polyfluoroalkyl substances, are synthetic chemicals utilized in numerous consumer products, ranging from nonstick cookware and waterproof clothing to stain-resistant carpets. Extensive research has shown that exposure to PFAS can lead to various health issues, including metabolic disorders, reduced fertility, developmental delays in children, and heightened risks of prostate, kidney, and testicular cancers.As part of this settlement, 3M's payment will be distributed over a period of 25 years to cover damages, cleanup efforts, and the treatment of drinking water in affected areas. However, DuPont and Chemours—DuPont's spinoff that currently manages the Chambers Works facility—are not included in this settlement agreement and remain subjects of ongoing legal proceedings. DuPont has refrained from commenting on the matter currently.

Topics

More on this story